Latest Regulatory Compliance News

Latrobe Magnesium Limited has addressed ASX concerns over recent share price and volume spikes, attributing the market activity to recognition of its asset value and the imminent start of its demonstration plant.

Macarthur Minerals has updated its rights issue prospectus, introducing a cap on the underwriter's shareholding and revising key offer terms. These changes aim to balance funding needs with shareholder control and regulatory compliance.

Nyrada Inc. is set to launch a Phase IIa clinical trial of Xolatryp™, aiming to reduce heart muscle damage in acute myocardial infarction patients undergoing PCI. The trial, planned for early 2026, follows promising Phase I safety results and strong preclinical cardioprotection data.

Hutchison Telecommunications (Australia) Limited has been suspended from ASX trading following compulsory acquisition notices issued by its Amsterdam-based parent company.

Prodigy Gold NL has lodged a replacement Appendix 3Y to amend the reported securities held by Managing Director Mark Edwards following his participation in the company’s recent Entitlement Offer.

Kingsland Minerals has withdrawn its previously implied production target for the Leliyn Graphite Project’s processing plant, citing non-compliance with ASX disclosure rules and advising investors to disregard prior estimates.

Macarthur Minerals has extended the timetable for its A$2 million renounceable rights issue, providing shareholders additional time to participate amid ongoing regulatory scrutiny by ASIC. The company confirms no changes to the offer terms and expects to lodge an updated Supplementary Prospectus shortly.

Rimfire Pacific Mining’s securities remain suspended on the ASX due to a delayed announcement on its proposed capital raising and ongoing arbitration with Golden Plains Resources. The suspension continues until regulatory compliance is restored.

Austal Limited has acknowledged a delayed filing of a director's interest notice due to an administrative oversight, prompting ASX scrutiny and a commitment to tighten compliance processes.

Genetic Signatures has formed a strategic partnership with Tecan and Repado to develop a fully automated, scalable infectious disease testing platform integrating advanced automation, compliant software, and proprietary assays.

Genmin Limited has raised an additional A$1 million in unsecured loans from key board members to support working capital for its flagship Baniaka iron ore project in Gabon.

Argosy Minerals Limited has launched a $2 million placement accompanied by an offer of up to 40 million options, aiming to bolster development and feasibility efforts at its Rincon Lithium Project in the USA.